AIM
Aigen Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,274
| Closed | -$597K | – | 1042 |
|
|
2024
Q2 | $597K | Buy |
+1,274
| New | +$597K | 0.12% | 254 |
|
|
2023
Q3 | – | Sell |
-4,358
| Closed | -$1.53M | – | 1105 |
|
|
2023
Q2 | $1.53M | Buy |
+4,358
| New | +$1.53M | 0.23% | 127 |
|
|
2022
Q4 | – | Sell |
-6,692
| Closed | -$1.94M | – | 794 |
|
|
2022
Q3 | $1.94M | Buy |
6,692
+5,436
| +433% | +$1.57M | 0.28% | 109 |
|
|
2022
Q2 | $354K | Buy |
+1,256
| New | +$354K | 0.06% | 364 |
|
|
2022
Q1 | – | Sell |
-4,059
| Closed | -$867K | – | 1123 |
|
|
2021
Q4 | $867K | Sell |
4,059
-5,465
| -57% | -$1.17M | 0.05% | 463 |
|
|
2021
Q3 | $1.73M | Sell |
9,524
-20,607
| -68% | -$3.74M | 0.33% | 83 |
|
|
2021
Q2 | $6.08M | Buy |
+30,131
| New | +$6.08M | 1.06% | 16 |
|
|
2020
Q4 | – | Sell |
-20,899
| Closed | -$5.69M | – | 1099 |
|
|
2020
Q3 | $5.69M | Sell |
20,899
-7,804
| -27% | -$2.12M | 0.73% | 9 |
|
|
2020
Q2 | $8.33M | Buy |
28,703
+1,489
| +5% | +$432K | 1.07% | 2 |
|
|
2020
Q1 | $6.48M | Buy |
27,214
+8,037
| +42% | +$1.91M | 0.86% | 6 |
|
|
2019
Q4 | $4.2M | Buy |
+19,177
| New | +$4.2M | 0.7% | 15 |
|